STAT3 inactivation triggered by sorafenib has been shown to elicit different types of cancer cell death including apoptosis [28, 30, 31] and autophagy [32], possible via myeloid cell leukemia-1 (MCL1) downregulation. Here, MCL1 is linked to cancer.